Stratos Wealth Partners LTD. Grows Position in Cigna Group $CI

Stratos Wealth Partners LTD. raised its holdings in Cigna Group (NYSE:CI) by 10.7% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,615 shares of the health services provider’s stock after acquiring an additional 543 shares during the period. Stratos Wealth Partners LTD.’s holdings in Cigna Group were worth $1,856,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Family Legacy Inc. raised its holdings in shares of Cigna Group by 0.5% in the 1st quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after acquiring an additional 31 shares in the last quarter. Impact Investors Inc raised its holdings in shares of Cigna Group by 1.6% in the 1st quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after acquiring an additional 31 shares in the last quarter. Westend Capital Management LLC raised its holdings in shares of Cigna Group by 8.1% in the 1st quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after acquiring an additional 32 shares in the last quarter. Financial Network Wealth Advisors LLC raised its holdings in shares of Cigna Group by 26.8% in the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after acquiring an additional 34 shares in the last quarter. Finally, Central Pacific Bank Trust Division raised its holdings in shares of Cigna Group by 1.0% in the 2nd quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock valued at $1,137,000 after acquiring an additional 35 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CI. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Wolfe Research decreased their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. The Goldman Sachs Group began coverage on Cigna Group in a report on Tuesday, October 14th. They set a “buy” rating and a $370.00 price objective on the stock. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $369.89.

Cigna Group Trading Up 2.6%

NYSE:CI opened at $307.03 on Tuesday. The firm has a market capitalization of $81.96 billion, a P/E ratio of 16.76, a P/E/G ratio of 0.88 and a beta of 0.45. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a fifty day moving average of $297.87 and a 200 day moving average of $307.81. Cigna Group has a 52 week low of $256.89 and a 52 week high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.